Morning Seminar

MS2-13

Abyss of blood coagulation factor IX～Action in extravascular space～

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.13 (Osaka International Convention Center, 11F 1101-2)

Chair: Tadashi Matsushita (Department of Blood Transfusion Service Nagoya University Hospital)

Sponsor: Pfizer Japan Inc.

Morning Seminar

MS2-14

Role of RIT in patient with indolent NHL

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.14 (Osaka International Convention Center, 8F 801-2)

Chair: Norifumi Tsukamoto (Third Department of Internal Medicine, Gunma University, School of Medicine)

Sponsor: MUNDIPHARMA.K.K

Morning Seminar

MS2-15

Evaluation of MRD and Genomic Information in ALL

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.15 (Osaka International Convention Center, 7F 701-2)

Chair: Yosuke Minami (Department of Hematology, National Cancer Center Hospital East)

Sponsor: Amgen Astellas BioPharma K.K.

Morning Seminar

MS3-3

The history of ALL treatment and the role of Besponsa

Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.3 (Osaka International Convention Center, 12F Conference Hall)

Chair: Yoshinobu Maeda (Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Hematology, Oncology and Respiratory Medicine)

Sponsor: Pfizer Japan Inc.

Morning Seminar

MS3-4

The future of CML therapeutic strategy -when TFR (treatment-free remission) is an option in clinical practice-

Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.4 (Osaka International Convention Center, 12F 1202)

Chair: Chiaki Nakaseko (Department of Hematology, International University of Health and Welfare School of Medicine)

Sponsor: Novartis Pharma K.K.

Morning Seminar

MS3-5

Treatment strategy for B-cell Lymphoma in the post-genomic era-including optimal treatment for the elderly and management of adverse events-

Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.5 (Osaka International Convention Center, 12F Grand Toque)

Chair: Ken Ohmachi (Division of Hematology, Department of Internal Medicine, Tokai University of Medicine)

Sponsor: Kyowa Hakko Kirin Co., Ltd.

Morning Seminar

MS3-6

GVHD Management on Allogeneic Hematopoietic Cell Transplantation

Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.6 (Osaka International Convention Center, 10F 1003)

Chair: Makoto Onizuka (Hematology/Oncology, Tokai University School of Medicine)

Sponsor: Chugai Pharmaceutical Co., Ltd.

Morning Seminar

MS3-7

AL amyloidosis

Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.7 (Osaka International Convention Center, 10F 1001)

Chair: Chihiro Shimazaki (Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center)

Sponsor: Takeda Pharmaceutical Co.Ltd

Morning Seminar

MS3-8

Utility of multicolor flow cytometry for treatment of multiple myeloma - MRD measurement and fluctuation of microenvironment -

Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.8 (Osaka International Convention Center, 10F 1002)

Chair: Arinobu Tojo (Division of Molecular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo)

Sponsor: Janssen Pharmaceutical K.K.

Morning Seminar

MS3-9

Immunotherapy of multiple myeloma～Long-term follow-up data Positioning of Elotuzumab～

Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.9 (Osaka International Convention Center, 10F 1008)

Chair: Masahiro Kizaki (Department of Hematology, Saitama Medical Center, Saitama Medical University)

Sponsor: Bristol-Myers Squibb K.K.